Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-06-27

Clinical Trial Update: Preventing Epilepsy After Traumatic Brain Injury With Topiramate [EARLY_Phase 1]

View source ↗

Summary

Phase 1 trial evaluating topiramate to prevent epilepsy after traumatic brain injury was terminated early.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topiramate (Topiramate)

Snippet

Sponsor: University of Pennsylvania | Conditions: Traumatic Brain Injury, Epilepsy | EARLY_Phase 1 | Status: TERMINATED